In Tuesday’s trading session, shares of one of the leading players in the pharmaceuticals sector, specializes in the manufacturing and marketing of healthcare products, jumped up to 2 percent following the bulk deal of a 0.74 percent stake involving Sundaram Mutual fund
Price action
With a market capitalization of Rs. 1,978.64 crores on Tuesday, the shares of Amrutanjan Health Care Limited is trading at Rs. 685.95 up by 1.9 percent making a high of Rs. 688 per share compared to its previous closing price of Rs. 683.20 per share.
What happened
Amrutanjan Health Care Limited, a company specializing in the manufacturing and marketing of healthcare products, recently experienced a bulk deal in which Sundaram Mutual Fund sold a 0.74 percent stake. In this transaction, approximately 213,500 shares were sold at Rs. 700 each, resulting in a total value of around Rs. 14.95 Crores.
About the company
Amrutanjan Health Care Limited (AHCL) is a well-established Indian company that specializes in the manufacturing and marketing of healthcare products, particularly in the pain relief and wellness segment..
AHCL has expanded its product portfolio to include a range of healthcare solutions, such as therapeutic ointments, inhalers, and wellness products. With a focus on innovation and customer satisfaction, the company leverages its strong research and development capabilities to continuously introduce new products that address the evolving needs of the healthcare market.
Shareholding Pattern
The ownership structure of Amrutanjan Health Care Limited is as follows: the promoters hold 46.52 percent, Foreign Institutional Investors (FIIs) own 2.34 percent, Domestic Institutional Investors (DIIs) control 10.60 percent and the public holds 40.54 percent.
Financials
The company’s revenue rose by 10.3 percent from Rs 103.26 crore to Rs 113.97 crore in Q2FY24-25. Meanwhile, Net profit rose from Rs 6.85 crores to Rs 11.8 crore during the same period.
Key Financial ratios
Amrutanjan Health Care Limited has an impressive Return on Equity (RoE) of 15.96 percent and a Return on Capital Employed (RoCE) of 21.93 percent. Furthermore, the company’s debt-to-equity ratio is 0.01.
Written by Sridhar J
